Fyodor Bondarchuk

Fyodor Bondarchuk

Ask VT AI
View News Summary
  • Nets' rising star Cam Thomas signs one-year, $6M qualifying offer, setting up 2026 free agency
  • Bipartisan lawmakers propose ban on congressional stock trading to address conflicts of interest and restore public trust.
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Nets' rising star Cam Thomas signs one-year, $6M qualifying offer, setting up 2026 free agency
  • Bipartisan lawmakers propose ban on congressional stock trading to address conflicts of interest and restore public trust.
  • Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Fyodor Bondarchuk